|
 |
AczoneThis page contains recent news articles, when available, and an overview of Aczone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Web sites such as this one for Aczone acne medication are coming under scrutiny by state legislators concerned that drug marketers are ... BU Today Allergan Reports Third Quarter 2009 Operating Results - Oct 29, 2009 ...amortization of acquired intangible assets associated with the Inamed, Cornéal, EndoArt, Esprit, and Samil acquisitions and the ACZONE asset purchase. ... Reuters Allergan Marketing Spurs Sales, Snags - Nov 6, 2009 In August, regulators sent Allergan a warning letter about an ad for its Aczone acne medication, saying it overstated the drug's effectiveness and omitted ... Orange County Business Journal QLT announces third quarter results for 2009 - Oct 27, 2009 The decline occurred because the 2008 third quarter results included a $134 million gain from the sale of Aczone(R) and Atrigel(R) (within discontinued ... Reuters Novartis, QLT amend agreement on Visudyne treatment for blindness - Oct 19, 2009 Last year it sold its acne gel Aczone for $150 million to Allergan Inc., as well as the building that houses its Vancouver headquarters. ... The Canadian Press QLT Q3 2009 Earnings Call Transcript - Oct 27, 2009 ...compared to EPS of $1.97 in Q3 2008 that was driven by the gains last year on the sale of Aczone dapsone gel and our headquarter's land and building. ... Seeking Alpha (blog) FDA: Allergan Aczone ads were misleading - Aug 21, 2009 The US Food and Drug Administration on Friday released a letter to Allergan Inc. saying that the company's marketing and advertising efforts for Aczone, Bizjournals.com Allergan taps Twilight star for acne interactive - Aug 28, 2009 Allergan is tweaking two teen cultural sensations with a High School Musical-themed interactive campaign for its acne medication Aczone, starring Michael Medical Marketing and Media DDMAC warns Allergan, Galderma Labs on promo materials - Aug 24, 2009 The Division of Drug Marketing and Communications (DDMAC) warned Allergan about a journal ad for Aczone, and Galderma Laboratories about two professional Medical Marketing and Media Feds Chase Down Faulty Skincare Promos - Aug 26, 2009 Allergen got an even harsher letter, stating that its journal advertisement for the acne gel Aczone is a complete misrepresentation of the results of a PharmExec.com FDA Gives Allergan a Stats Lesson in Bold Type - Aug 24, 2009 That's one way to read a warning letter the FDA sent to Allergan regarding a journal ad for its Aczone acne product. The journal ad claims that “[ACZONE] BNET VIDEO: Michael Welch Wages War on Zits - Aug 14, 2009 In a hilarious new interview with Buzznet, Welch discusses his participation in Aczone: The Musical, a campaign to promote clear skin among the nation's Celebuzz Raptor raises $5M for merger; Wyeth takes over R&D work from Karo Bio; - Aug 25, 2009 Allergan got a warning letter from FDA on its acne treatment Aczone, and Galderma was slapped around a bit for its promotion of a hyperpigmentation FierceBiotech WSJ praises Valeant CEO's pay; Bayer to invest $1.4B in green ... - Aug 24, 2009 Report > The FDA has banned print advertisements for Allergan 's Aczone, an acne treatment. In a letter to the company, the agency said the ads were FiercePharma Social Media and Viral Branding Agency Luthier Society, Inc ... - Aug 16, 2009 Allergen, who recently launched their Aczone product line by developing a multi-media website and online video series at AczoneTheMusical.com, PR-USA.net (press release) FDA﹕Allergan生產的粉刺治療藥物Aczone療效被誇大 - Aug 21, 2009 ...國食å“?和藥物管ç?†å±€(Food and Drug Administration, 簡稱FDA)表示ï¹?Allergan Inc. (AGN)生產的粉刺霜Aczone的期刊廣告誇大了療效ï¹?而çœ?略了關é?µçš„安全信æ?¯ã€‚ 華爾街日報 FDA：Allergan生产的粉刺治疗è?¯ç‰©Aczone疗效被夸大 - Aug 21, 2009 ...国食å“?å’Œè?¯ç‰©ç®¡ç?†å±€(Food and Drug Administration, 简称FDA)表示，Allergan Inc. (AGN)生产的粉刺霜Aczone的期刊广告夸大了疗效，而çœ?略了关键的安全信æ?¯ã€‚ 华尔街日报 FDA, 앨러간 여드름약 ê´‘ê³ ì‹œì • 공문 발송 - Aug 23, 2009 FDA는 앨러간 여드름 ì¹˜ë£Œì œ'ì•„í?¬ì¡´(Aczone)'ì?˜ ê´‘ê³ ê°€ 약물ì?˜ 효과를 과장했다는 공문ì?„ 21ì?¼ 발송했다. 공문ì—?ì„œ FDA는 ì €ë„?ì—? 소개ë?œ ì•„í?¬ì¡´ì?˜ ê´‘ê³ ì—?ì„œ 위험ì—? 메디게이트뉴스 TOP MARKET NEWS - Feb 19, 2009 The results also included combined pre-tax gains on the divestures of Aczone and Atrigel of US$134.9 million. For fiscal year 2008, net income was US$134.89 RTT News QLT Announces Fourth Quarter and Year End 2008 Results - Feb 19, 2009 Our statement of operations for 2008 includes the results of Eligard within continuing operations, while financial results related to Aczone(R) and PR Newswire (press release) QLT ANNOUNCES FOURTH QUARTER AND YEAR END 2008 RESULTS - Feb 20, 2009 Our statement of operations for 2008 includes the results of Eligard within continuing operations, while financial results related to Aczone® and Atrigel® Lifescience-online Acne armamentarium Recently approved drugs increase dermatologists ... - Jan 19, 2009 Dr. Del Rosso also reviewed recent safety data on dapsone 5 percent gel (Aczone, Allergan). Results from a study enrolling patients with G6PD deficiency Modern Medicine, QLT says Q4 sales of Visudyne down 32.7 per cent compared with ... - Jan 12, 2009 It sold its acne gel Aczone for $150 million to Allergan Inc. and has also cut staff and sold its headquarters. Shares in the company, which announced the News1130, US Court of Appeals upholds unfair trade practices decision ... - Jan 13, 2009 It already sold its acne gel Aczone for $150 million to Allergan Inc. and has also cut staff and sold its headquarters. Butchofsky said Tuesday that he The Canadian Press, QLT shares buck falling market on buyback - Dec 1, 2008 It already sold its acne gel Aczone for $150 million to Allergan Inc. and has also cut staff and sold its headquarters. The tender offer will start on or CNNMoney.com Examine the World Medicated Skin Care Products Market - Dec 16, 2008 Recent Industry Activity II-18 Stiefel Laboratories Acquires Barrier Therapeutics II-18 Allergan to Acquire Aczone(R) Gel 5% II-18 Barrier Therapeutics MarketWatch DGAP-News: Nalco Mobotec uczestnikiem konsorcjum ktore wygra?o ... - Dec 21, 2008 Stwierdzenia zwiazane z przysz?o?cia moga by? po?aczone ze znanym i ?e rzeczywiste wyniki beda istotnie ro?ni? sie od spodziewanych, Financial.de (Pressemitteilung), QLT eyes share buyback as divestitures provide cash - Oct 28, 2008 Earlier this year, the company announced restructuring measures, including the sale of its US operations whose primary assets Eligard; Aczone, a dermatology Forbes, Allergan Reports Third Quarter 2008 Operating Results - Oct 29, 2008 On July 14, 2008, Allergan announced that its wholly-owned subsidiary, Allergan Sales, LLC, completed the acquisition of ACZONE(R) (dapsone) Gel 5%, MarketWatch QLT announces third quarter results for 2008 - Oct 28, 2008 The combined pre-tax gains on the divestures of Aczone(R) and Atrigel(R) of $134.3 million were reported as part of income from discontinued operations. SYS-CON Brasil, QLT's Atrigel licensed for addiction treatment - Sep 26, 2008 The company's products include Eligard, a prostate cancer treatment; Aczone, for the treatment of acne; and Atrigel. The company announced a sweeping Northern Colorado Business Report, Allergan Names Pacific Communications Agency of Record for Aczone ... Aug 25, 2008 25, 2008--Allergan Medical Dermatology has chosen Pacific Communications as agency of record to launch ACZONE® Gel 5%, first of a new class of treatment forPharmaLive.com (press release), QLT to licence its Atrigel technology Aug 26, 2008 QLT previously sold worldwide rights to its acne gel Aczone to California-based Allergan Inc. (NYSE: AGN) for US$150 million in cash.Toronto Star, QLT Inc. Q2 2008 Earnings Call Transcript Aug 20, 2008 In June, we signed an agreement to sell Aczone to Allergan, the deal which we recently completed. We show that our clinical and regulatory strategy pursuedSeeking Alpha, A Big Upgrade for Allergan Aug 19, 2008 In a separate move, the company purchased the rights to QLT's (Nasdaq: QLTI) acne drug Aczone for $150 million cash, hoping to capture as much of the $800Motley Fool Allergan Completes Acquisition of Aczone Gel 5% - Jul 14, 2008 As previously announced, Allergan paid approximately $150 million for all assets relating to Aczone ® Gel 5%. Allergan will not alter financial guidance for Business Wire (press release), QLT announces second quarter results for 2008 - Jul 29, 2008 The reported June 30, 2008 cash balance does not include the $150 million received in July upon closing of the Aczone divestment to Allergan Sales, LLC. MSN Money Allergan acquires Aczone gel from QLT - Jul 15, 2008 As previously announced, Allergan paid approximately $150 million for all assets relating to Aczone gel 5%. Allergan expects to launch Aczone gel 5% in the Trading Markets (press release), QLT offloads acne drug in US$150 million deal as Vancouver biotech ... - Jul 15, 2008 QLT Inc. (TSX:QLT; Nasdaq:QLTI) has sold its Aczone topical acne treatment to a subsidiary of California-based Allergan Inc. for US$150 million. Business in Vancouver, Allergan Reports Second Quarter 2008 Operating Results - Jul 30, 2008 On July 14, 2008, Allergan announced that its wholly-owned subsidiary, Allergan Sales, LLC, completed the acquisition of ACZONE(R) (dapsone) Gel 5%, Genetic Engineering News (press release), Actavis faces nine Digitek suits; NJ court tosses out hormone case - Jul 14, 2008 Report > Botox maker Allergan said Monday it completed the $150 million purchase of acne treatment gel Aczone from QLT USA Inc. Report > A new survey of New FiercePharma, Other News To Note - Jul 14, 2008 QLT Inc., of Vancouver, British Columbia, said that its US subsidiary completed the sale of Aczone (dapsone) Gel, a topical treatment for acne vulgaris, TMCnet Allergan Reports Second Quarter 2008 Operating Results - Jul 30, 2008 On July 14, 2008, Allergan announced that its wholly-owned subsidiary, Allergan Sales, LLC, completed the acquisition of ACZONE(R) (dapsone) Gel 5%, Newsdesk (pressmeddelande), Allergan buys QLT acne gel Aczone for $150 million - Jun 9, 2008 NEW YORK (Associated Press) - Allergan Inc. said Monday that it would acquire QLT Inc.'s acne gel Aczone for $150 million. The deal is expected to close in CNNMoney.com QLT announces positive Health Canada decision on Aczone(R) - Jun 6, 2008 ..."We are extremely pleased to report Health Canada's decision to remove the need for blood monitoring from the Aczone label," said Bob Butchofsky, FOXBusiness QLT announces positive Health Canada decision on Aczone(R) - Jun 6, 2008 ...'We are extremely pleased to report Health Canada's decision to remove theneed for blood monitoring from the Aczone label,' said Bob Butchofsky ,President istockAnalyst.com, QLT To Sell Aczone For $150 Million - Jun 11, 2008 ..."The divestment of Aczone is a major milestone for QLT and this transaction demonstrates that our persistence in completing the work needed to remove the HULIQ (press release), Allergan to acquire Aczone Gel for; financial view unchanged - Jun 9, 2008 By John Ittner , , ) said Monday that it had agreed to buy QLT's Aczone gel, an acne treatment, for $150 million. Allergan plans to launch Aczone in the MarketWatch EXECUTIVE SUMMARY - Jun 14, 2008 Allergan is buying Aczone from Vancouver, British Columbia’s QLT Inc. in a deal expected to close in the third quarter. The company expects yearly sales of Orange County Business Journal, Canadian markets soar, then finish flat - Jun 10, 2008 Vancouver-based biotechnology firm QLT added 17 cents, or four per cent, to $4.03 after the company sold its acne gel medication Aczone for $150 million US Vancouver Sun, Agrium, Bombardier, Isotechnika, JumpTV: Canada Stock Movers - Jun 9, 2008 The drugmaker sold its new acne drug Aczone to Allergan Inc. (AGN US), maker of the wrinkle remover Botox, for $150 million. Bloomberg Abitibi, Bombardier, Canfor, Manulife: Canadian Stock Preview - Jun 9, 2008 QLT Inc. (QLT CN): The drugmaker sold its new acne drug Aczone to Allergan Inc. (AGN US), maker of the wrinkle remover Botox, for $150 million. Bloomberg QLTI: Allergan to Acquire Aczone(R) (Dapsone) Gel 5% for $150M - Jun 9, 2008 Allergan will pay approximately $150 million for all assets relating to Aczone(R) Gel 5% upon closing, which is expected to occur in the third quarter of Trading Markets (press release), Merck KGaA snags rights to 30 BMS meds; Shire taps Bacardi exec as ... - Jun 10, 2008 Release > Allergan has inked a deal to buy QLT's Aczone gel 5 percent product, a topical treatment for acne vulgaris, for $150 million. FiercePharma, Energy stocks lift TSX even as oil moves lower;NY higher following ... - Jun 9, 2008 QLT Inc. (TSX:QLT) gained 23 cents to $4.09 after it sold its worldwide rights to acne gel Aczone to Allergan Inc. for US$150 million. News1130, Allergan pays Canadian firm $150M for acne drug - Jun 10, 2008 Allergan has agreed to pay $150 million for Aczone, an acne treatment from Canadian drugmaker QLT, as it seeks to capture a younger market. SmartBrief, TFN NEWS BRIEFING: Mergers and acquisitions highlights to 15:50 BST - Jun 9, 2008 ...(AP) - Allergan Inc. said Monday that it would acquire QLT Inc.'s acne gel Aczone for $150 million. MILAN (Thomson Financial) - Air France-KLM's chairman Interactive Investor, TFN NEWS BRIEFING: Mergers and acquisitions highlights to 15:50 BST - Jun 9, 2008 ...(AP) - Allergan Inc. said Monday that it would acquire QLT Inc.'s acne gel Aczone for $150 million. MILAN (Thomson Financial) - Air France-KLM's chairman Hemscott, Movers: Lehman, AIG, Hilb Rogal & Hobb, Cost Plus - Jun 9, 2008 QLT (QLTI) says its QLT USA Inc. unit has entered into an asset purchase agreement with a unit of Allerganto fully divest QLTI's worldwide rights to Aczone, BusinessWeek Market Report -- In Play (QLTI) - Jun 6, 2008 QLT announces positive Health Canada decision on Aczone Co announces that Health Canada has completed its review of QLT's labeling supplement for Aczone and MSN Money JumpTV merging with NeuLion - Jun 10, 2008 VANCOUVER -- It's two deals down and two to go for drugmaker QLT Inc., (TSX:QLT) which on Monday announced the sale of its acne gel Aczone to The North Bay Nugget, Stock market outlook mixed as oil pulls back slightly, Lehman ... - Jun 9, 2008 In early Canadian corporate news, QLT Inc. (TSX:QLT) has sold its worldwide rights to acne gel Aczone to Allergan Inc. for US$150 million. 660 News, A Good Mix for QLT - Mar 31, 2008 ...compared with the double that QLT hit two weeks ago when the Food and Drug Administration lifted some of the restrictions on its acne treatment Aczone. Motley Fool QLT reports 40 per cent decline Visudyne blindness treatment sales ... - Mar 3, 2008 In addition to Eligard, QLT USA also includes the company's Aczone acne drug which is nearing commercialization and its Atrigel drug delivery system. AOL Canada, Drug firm QLT up 24 per cent after company signals it's for sale - Mar 3, 2008 O'Connor pointed to growing revenue from Eligard, the potential of the company's acne treatment Aczone that could be launched as early as next summer and AOL Canada, QLT Announces 2007 Results - Feb 21, 2008 For the full year, expenditures for R and D in 2007 were $46.4 million, down from $56.4 million in 2006 primarily due to decreased spending on Aczone(TM) Lifescience-online, QLT Inc. plans to shed USA operations - Feb 15, 2008 The company's products include Eligard, a prostate cancer treatment; Aczone, a dermatology product for the treatment of acne; and Atrigel, a drug delivery Northern Colorado Business Report, |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
